You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy

 

Online download statistics by month:

Online download statistics by month: June 2022 to July 2025

AbstractFullPdf
Jun 2022780813311
Jul 202230831091
Aug 202225726290
Sep 202227828187
Oct 202225125569
Nov 202220920958
Dec 202219219249
Jan 202316016060
Feb 2023126130101
Mar 2023909052
Apr 2023929239
May 2023787948
Jun 2023646426
Jul 202311811889
Aug 2023666620
Sep 2023616527
Oct 2023626825
Nov 2023616526
Dec 2023484817
Jan 2024616337
Feb 2024555538
Mar 2024838377
Apr 2024686845
May 2024697032
Jun 2024808142
Jul 2024818241
Aug 2024485067
Sep 2024606035
Oct 2024595917
Nov 2024343529
Dec 2024505126
Jan 2025414122
Feb 202516416538
Mar 2025525243
Apr 2025707033
May 2025525344
Jun 2025313141
Jul 2025110
Total446045371992